K103173 is an FDA 510(k) clearance for the VITOSS BA BIMODAL BIOACTIVE BONE GRAFT SUBSTITUTE. Classified as Filler, Bone Void, Calcium Compound (product code MQV), Class II - Special Controls.
Submitted by Orthovita, Inc. (Malver, US). The FDA issued a Cleared decision on February 7, 2011 after a review of 102 days - within the typical 510(k) review window.
This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3045 - the FDA orthopedic device regulatory framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.
Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.